期刊文献+

几种肝脏病变的MRI菲立磁增强表现及诊断价值 被引量:1

Superparamagnetic iron-oxide(SPIO) enhanced MRI manifestations and diagnostic value in several liver diseases
下载PDF
导出
摘要 目的:探讨菲立磁(SPIO)增强在肝脏病变中的诊断价值。方法:16例患者行SPIO增强的MRI检查,其中6例为海绵状血管瘤,不均匀脂肪肝4例,肝细胞癌(HCC)3例,局灶结节增生(FNH)、肝腺瘤及肝转移瘤各1例。结果:与MRI平扫相比,肝内海绵状血管瘤在SPIO增强后的T1WI上信号明显增高,而在T2WI上信号强度有轻度下降;在不均匀脂肪肝的病例中,增强后兴趣区与周围肝组织的信号强度对比关系延续了增强前的表现;肝腺瘤和FNH在增强后的T2WI上有明显的信号强度下降:HCC在增强后的T2WI上常无明显信号下降,而在T1WI上却有轻度信号升高;转移瘤在T2WI上无信号下降。结论:SPIO强化MRI对肝内病变的良恶性鉴别诊断有一定的帮助。 Objective:To explore SPIO-enhanced MRI appearances and research its diagnostic value in several kinds of liver diseases. Methods:SPIO-enhanced MRI examination was performed in 16 cases, among 6 cases were cavernous hemangioma, four heterogeneous fatty liver, three HCC, one FNH, one hepatic adenoma and one hepatic metastasis. Results: By comparison with unenhanced MRI, cavernous hemangioma was a higher signal intensity on SPIO-enhanced T1WI, and slightly lower signal intensity on T2WI. In the cases with fatty liver, the signal ratio of the region of interest and surrounding liver was the same as unenhanced MRI examination. There was a evident decrease of signal intensity on SPIO-enhanced T2WI in hepatic adenoma and FNH. However, in HCC cases, there was no marked decrease on T2WI and has slightly increased signal on T1WI. There was no decreased signal on SPIO-enhanced T2WI in the case with metastasis. Conclusion:SPIO-enhanced MRI can asist to diagnose liver disease.
出处 《医学影像学杂志》 2005年第11期957-960,共4页 Journal of Medical Imaging
关键词 菲立磁 磁共振成像 肝脏病变 Superparamagnetic iron-oxlde Magnetic resonance imaging Liver disease
  • 相关文献

参考文献6

  • 1郑蔚巍,周康荣,陈祖望,沈继章,陈财忠,张澍杰.超顺磁性氧化铁在肝脏局灶性病变中的定性研究[J].临床放射学杂志,2001,20(4):246-250. 被引量:10
  • 2Vogi TJ, Hammerstingi R, Schwarz W, et al. Superparamagnetic iron oxide-enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesion[J].Radiology,1996,198:881.
  • 3Reimer P, Jahnke N, Fiebich M, et al.Hepatic lesion detection and characterization: value of nonenhanced MR imaging.Superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis[J]. Radiology,2000:217:152.
  • 4徐隽,宋彬,闵鹏秋.肝脏磁共振对比剂研究现状及发展方向[J].临床放射学杂志,2001,20(9):716-719. 被引量:3
  • 5Hirohashi S ,Ueda K, Uchida H, et al. Nondiffuse fatty change of the liver discerning pseudotumor on MR images enhanced with ferumoxides inital observations[J].Radiology, 2001,217:415.
  • 6Yamamaoto H, Yamashita Y, Yoshimatsu S, et al. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide enhanced MR imaging[J].Radiology, 1995,195:106.

二级参考文献23

  • 1[1]Mahfouz AE, Hamm B, Taupitz M. Contrast agents for MR imaging of the liver: A clinical overview. European Radiology, 1997, 7:507
  • 2[2]Hahn PF, Saini S. Liver-specific MR imaging contrast agents. Radiol Clin North Am, 1998, 36:287
  • 3[3]Hamm B, Thoeni RF, Gould RG,et al. Focal liver lesions: Characterization with nonenhanced and dynamic contrast material-enhanced MR imaging. Radiology, 1994, 190:417
  • 4[4]Mahfouz AE, Hamm B, Taupitz M,et al. Hypervascular liver lesions: Differentiation of focal nodular hyperplasia from malignant tumors with dynamic Gadolinium-enhanced MR images. Radiology, 1993, 186:133
  • 5[5]Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: A sign of malignancy on dynamic Gadolinium-enhanced MR images of focal liver lesions. Radiology, 1994, 190:49
  • 6[6]Mahfouz AE, Hamm B, Wolf KJ. Dynamic gadopentetate dimeglumine-enhanced MR imaging of hepatocellular carcinoma. European Radiology, 1993, 3:453
  • 7[7]Stark DD, Weissleder R, Elizondo G,et al. Superparamagnetic iron oxide: Clinical application as a contrast agent for MR imaging of the liver. Radiology, 1988, 168:106
  • 8[8]Yamamoto H, Yamashita Y, Yoshimatsu S,et al. Hepatocellular carcinoma in cirrhotic liver: Detection with unenhanced and iron oxide-enhanced MR imaging. Radiology, 1995, 195:106
  • 9[9]Ros PR, Freeny PC, Harms SE,et al. Hepatic MR imaging with ferumoxides: A multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology, 1995, 196:481
  • 10[10]Seneterre E, Taourel P, Bouvier Y,et al. Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology, 1996, 200:785

共引文献11

同被引文献14

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部